LLY

914.82

+1.5%↑

JNJ

239.95

+2.09%↑

ABBV

206.56

+0.92%↑

NVS

150.73

+1.58%↑

MRK

119.31

+2.59%↑

LLY

914.82

+1.5%↑

JNJ

239.95

+2.09%↑

ABBV

206.56

+0.92%↑

NVS

150.73

+1.58%↑

MRK

119.31

+2.59%↑

LLY

914.82

+1.5%↑

JNJ

239.95

+2.09%↑

ABBV

206.56

+0.92%↑

NVS

150.73

+1.58%↑

MRK

119.31

+2.59%↑

LLY

914.82

+1.5%↑

JNJ

239.95

+2.09%↑

ABBV

206.56

+0.92%↑

NVS

150.73

+1.58%↑

MRK

119.31

+2.59%↑

LLY

914.82

+1.5%↑

JNJ

239.95

+2.09%↑

ABBV

206.56

+0.92%↑

NVS

150.73

+1.58%↑

MRK

119.31

+2.59%↑

Search

Vivani Medical

Закрыт

1.12 -1.75

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

1.1

Макс.

1.13

Ключевые показатели

By Trading Economics

Доход

614K

-6.5M

Сотрудники

37

Дивиденды

By Dow Jones

Следующий отчет о доходах

30 мар. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-25M

79M

Предыдущая цена открытия

2.87

Предыдущая цена закрытия

1.12

Vivani Medical График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

25 мар. 2026 г., 20:20 UTC

Приобретения, слияния, поглощения

Infosys Agrees to Acquire Stratus

25 мар. 2026 г., 23:58 UTC

Отчет

Guming Proposes 2025 Final Dividend of HK$0.50 >1364.HK

25 мар. 2026 г., 23:58 UTC

Отчет

Guming: Seek to Further Expand Coffee Product Line, Explore New Food Categories >1364.HK

25 мар. 2026 г., 23:57 UTC

Отчет

Guming: Aim to Expand Store Network in China, Evaluate Overseas Opportunities >1364.HK

25 мар. 2026 г., 23:57 UTC

Отчет

Guming Store Network Rose 37% on Year to 13,554 Stores as of Dec. 31, 2025 >1364.HK

25 мар. 2026 г., 23:56 UTC

Отчет

Guming 2025 Rev CNY12.91B Vs. CNY8.79B >1364.HK

25 мар. 2026 г., 23:56 UTC

Отчет

Guming 2025 Net CNY3.11B Vs. Net CNY1.48B >1364.HK

25 мар. 2026 г., 23:41 UTC

Обсуждения рынка

Nikkei May Trade Rangebound Amid Uncertainty Over U.S.-Iran Talks -- Market Talk

25 мар. 2026 г., 23:41 UTC

Отчет

These Stocks Are Today's Movers: Arm, Intel, AMD, Firefly Aerospace, Robinhood, JD.com, Sarepta, and More -- Barrons.com

25 мар. 2026 г., 23:34 UTC

Обсуждения рынка
Главные новостные события

Gold Declines on Possible Technical Correction -- Market Talk

25 мар. 2026 г., 22:08 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

25 мар. 2026 г., 22:08 UTC

Обсуждения рынка

Synlait Milk's Outlook Depends on Dunsandel -- Market Talk

25 мар. 2026 г., 22:07 UTC

Отчет

China Mengniu Dairy: Weak Consumer Demand Weighed on Rev >2319.HK

25 мар. 2026 г., 22:07 UTC

Отчет

China Mengniu Dairy Plans Steady Increase in Dividends For Next Three Years >2319.HK

25 мар. 2026 г., 22:07 UTC

Отчет

China Mengniu Dairy: 2025 Net Supported by Absence of Impairment Provisions Made Last Year >2319.HK

25 мар. 2026 г., 22:07 UTC

Отчет

China Mengniu Dairy 2025 Rev CNY82.24B Vs. CNY88.67B >2319.HK

25 мар. 2026 г., 22:07 UTC

Отчет

China Mengniu Dairy 2025 Net CNY1.55B Vs. Net CNY104.51M >2319.HK

25 мар. 2026 г., 21:58 UTC

Обсуждения рынка

Amplitude Energy Oversold on Isabella-1 Well Disappointment -- Market Talk

25 мар. 2026 г., 21:37 UTC

Обсуждения рынка

Miran: AI and Deregulation Are Positive Supply Shocks To Economy -- Market Talk

25 мар. 2026 г., 21:14 UTC

Приобретения, слияния, поглощения

St Barbara: Expects to Record Gain on Sale of Roughly A$500 Million Upon Completion

25 мар. 2026 г., 21:13 UTC

Приобретения, слияния, поглощения

St Barbara: All Conditions Satisfied, Waived on Lingbao Deal

25 мар. 2026 г., 21:12 UTC

Приобретения, слияния, поглощения

Closing M&A Deals Bring Opportunity. Janus Henderson and Other Stocks to Buy. -- Barrons.com

25 мар. 2026 г., 20:50 UTC

Обсуждения рынка

Financial Services Roundup: Market Talk

25 мар. 2026 г., 20:50 UTC

Обсуждения рынка
Приобретения, слияния, поглощения

Health Care Roundup: Market Talk

25 мар. 2026 г., 20:33 UTC

Приобретения, слияния, поглощения

KKR & Co.: Entered Agreement to Sell CoolIT Systems to Ecolab in Transaction Valued at $4.75B >KKR >KKR

25 мар. 2026 г., 20:31 UTC

Отчет

The SpaceX IPO Is Coming. Cathie Wood's Ark Venture and More Funds to Get in on the Action. -- Barrons.com

25 мар. 2026 г., 20:15 UTC

Приобретения, слияния, поглощения

KKR Scores One of Its Best Bets With Sale of Data-Center Cooling Business -- WSJ

25 мар. 2026 г., 20:15 UTC

Приобретения, слияния, поглощения

CoolIT Employees Set to Receive Average Payouts of $240,000, Executives Say -- WSJ

25 мар. 2026 г., 20:15 UTC

Приобретения, слияния, поглощения

CoolIT Deal Ranks Among KKR's Top-4 Highest Earning Investments in Past 20 Years, Executives Say -- WSJ

25 мар. 2026 г., 20:15 UTC

Приобретения, слияния, поглощения

KKR Set to Make 15x Investment From $4.75B Sale of CoolIT to Ecolab, Executives Say -- WSJ

Сравнение c конкурентами

Изменение цены

Vivani Medical Прогноз

Консенсус по рейтингу

By TipRanks

0 ratings

0

Покупка

0

Удержание

0

Продажа

Финансовые показатели

Расходы на продажи и администрирование

Прибыль до уплаты налогов

Продажи

Операционная прибыль

$

О компании Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.
help-icon Live chat